(Q28244078)

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Endothelin-1 and the regulation of vascular tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Role of endothelin-1 in lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

The endothelin system in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Identification and characterization of two isoforms of an endothelin-converting enzyme-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Cloning and expression of a cDNA encoding an endothelin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Developmental effects of endothelin-1 on the pulmonary circulation in sheep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Pulmonary hypertension in children: perioperative management

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Pulmonary vascular disease with congenital heart lesions: pathologic features and causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Diagnosis and management of postoperative pulmonary hypertensive crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Flow-induced pressure differentially regulates endothelin-1, urotensin II, adrenomedullin, and relaxin in pulmonary vascular endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Bosentan prevents hypoxia-reoxygenation-induced pulmonary hypertension and improves pulmonary function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Endothelin in myocardial ischaemia and reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Endothelin antagonism with bosentan: a review of potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Endothelin receptor blockade reduces ventricular dysfunction and injury after reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Endothelins and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Endothelin peptides and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13

Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F01.PDR.0000160447.83332.13